Dr. Douglas Murphy-Chutorian has served as a member of our board of directors since September 2012, as our chief executive officer since October 2012 (except from April 1-27, 2023). Dr. Murphy-Chutorian has had broad, diverse career experience in healthcare over the past 30 years, spanning positions including clinician, academician, inventor, entrepreneur, chief executive officer, chairman of the board, and consultant to financial firms. From 2005 to 2012, he was managing director of Select Healthcare Capital, LLC. Dr. Murphy-Chutorian is a named inventor on more than 30 patents, and has guided more than 50 products through various regulatory approval processes. His business career has included extensive involvement in all facets of the medical industry from financial, research and development, manufacturing, marketing and sales, regulatory, reimbursement, and clinical trials. His breadth of healthcare experience includes all major sectors of the industry: medical devices, health services, pharmaceuticals, biotechnology and managed care. He received his B.A. and M.D. from Columbia University. He completed his internal medicine residency at New York University/Bellevue Medical Center and his fellowship in cardiology at Stanford University Medical Center. He has served as a faculty member in interventional cardiology at both Stanford and Montefiore Medical Center.

Ms. Oliva Herrington joined Semler in October 2010. She currently serves as our chief operating officer, overseeing our sales, technical and training operations, driving new strategies and launching and delivering new programs and products. She is a seasoned executive, expert at working within Medicare Advantage and Managed Care environments including health plans, IPAs, ACOs, MSOs and health risk assessment companies.

Ms. Cormier joined Semler in May 2022. As our chief financial officer, she leads our accounting, finance, investor relations and business strategy efforts. Ms. Cormier has extensive investing, finance and accounting experience and was most recently a partner at a buy side investment firm focusing on public equity securities.

Mr. Reid joined Semler in April 2019. As our chief technology officer, he leads our team of engineers and IT professionals who deliver clinical algorithms, mobile and desktop applications, hardware, healthcare system interconnects and cloud based services. He has wide-ranging experience as an engineer and manager, from the smallest scale start-up to large, multi-divisional organizations.

Ms. Guinasso joined Semler in October 2010. As senior vice president of business development, she is responsible for spearheading and executing our company’s business development plans, business model development, strategic partnerships and go-to market strategy and commercialization efforts. She is an experienced healthcare executive with extensive expertise in the healthcare services and med-tech industries.